SyrSpend® SF PH4 NEO has a new brochure!

News | 2 min read

Fagron’s range of oral suspending vehicles, SyrSpend® SF, offers a solution for different patient groups by providing pharmaceutical stability, dosage consistency, and patient comfort with each preparation. The content was updated to provide you with a better understanding of this specific pediatric subgroup and how SyrSpend® SF PH4 NEO can facilitate their personalized treatment.

One of the most important precepts of pediatric care is that children cannot be considered small adults as they differ in many aspects from the other age groups and require particular considerations while developing medication to target their needs. Infancy and childhood mark a period of rapid growth and development in which organs and systems are still immature and may result in differences in pharmacokinetics. Medicines specially designed for children should offer flexible dosing, be easy to swallow, address palatability issues, and contain only safe ingredients. Therefore, SyrSpend® SF PH4 NEO is free of sugar, sorbitol, colorants, parabens, or any other harmful or controversial ingredients, making it suitable for all patient groups, especially neonates and infants.

We hope you find the additional content informative and inspiring as you continue to explore the many possibilities that SyrSpend® SF PH4 NEO offers.

Click on the image below to read it.